
Mineral Resources is emerging from a heavy investment phase as the Onslow Iron project reaches scale, driving a sharp recovery in earnings and cash flow. With iron ore production ramped up and lithium assets backed by a major POSCO partnership, the business is now showing the financial benefits of years of expansion. Despite the turnaround, the stock still appears undervalued relative to its long‑term earnings, cash‑flow potential, and asset base.

Geopolitical tensions and supply disruptions have pushed global oil and gas prices higher. When benchmarks rise, ASX energy producers—especially upstream and LNG exporters—often see stronger revenues and margins due to robust demand from Asian markets.

TechnologyOne is a leading Australian SaaS provider delivering cloud ERP software to governments and large organisations. Its recurring revenue model supports strong margins and steady growth. However, the stock trades at a premium valuation, leaving little margin for growth disappointments.

Beach Energy is a gas-focused Australian producer supplying the domestic east coast market, with most output coming from the Cooper, Otway and Perth basins. The key growth driver is the Waitsia Gas Project, which could lift production and cash flow as it ramps up. The stock offers a high fully franked dividend but remains sensitive to energy prices and project execution.

Paladin Energy is a leveraged uranium producer centred on the restarted Langer Heinrich mine in Namibia. Its earnings are highly sensitive to uranium prices, making the stock a direct play on the nuclear fuel cycle. Future growth could come from the large Patterson Lake South project in Canada.

Yancoal Australia is largely a pure play on global coal prices, with profits rising and falling almost directly with commodity cycles. The company has dramatically strengthened its balance sheet, eliminating over $3bn of debt and building more than $2bn in cash, giving it one of the most conservative capital structures among coal producers. Even after coal prices normalised, low operating costs allow the business to remain profitable with solid cash flow and sustainable production levels.

Immutep is a Sydney-based clinical-stage biotechnology company focused on immunotherapy, specifically targeting the LAG-3 immune pathway. The company is dual-listed on the ASX and NASDAQ, giving it access to both Australian and US capital markets. It does not yet generate commercial product revenue and remains dependent on capital markets and partnerships to fund its development programs, making it a milestone-driven investment rather than a revenue-backed operating business.

Monadelphous Group is a high-quality, cycle-exposed engineering contractor leveraged to Australian resources and energy capex. Strong cash generation, a net cash balance sheet and disciplined contract selection underpin its reputation and dividend capacity. Long-standing Tier 1 client relationships support earnings resilience across mining, LNG and infrastructure projects. However, the current valuation suggests much of the favourable operating outlook is already priced in.

If you bought Neuren Pharmaceuticals (ASX: NEU) near its peak, the recent volatility has been uncomfortable. Despite having its first approved drug for a rare paediatric disorder, growing royalty income and a promising pipeline, the share price has repeatedly rallied and retraced over the past two years. The key question now is whether NEU has already formed a durable bottom — or if another leg down could still test investor conviction.

Fortescue Ltd is a low-cost iron ore producer with strong cash flow and attractive fully franked dividends, but earnings remain highly exposed to iron ore prices and Chinese demand. Trading around mid-cycle valuation levels, the stock looks fairly valued, with upside dependent on stronger commodity prices and successful expansion into magnetite and green energy.

WiseTech Global’s A$2bn acquisition of E2open has significantly boosted revenue but diluted margins and increased leverage, shifting the investment case from premium organic growth to execution-driven integration. While the long-term strategic rationale remains sound, near-term earnings pressure and higher balance sheet risk make valuation more demanding and leave little room for integration missteps.

PolyNovo Limited (ASX: PNV) remains a fundamentally strong, high-growth medtech, but its share price is currently testing key support around A$0.88–0.92 within a broader sideways range. While selling pressure has eased and momentum is stabilising, a confirmed bottom would require a sustained break above A$1.08; otherwise, a fall below A$0.86–0.90 could signal further downside.

Westpac Banking Corporation is a systemically important bank with a strong mortgage franchise, solid capital buffers and a fully franked dividend. With modest 3–4% earnings growth expected, current valuations look full, making it more suited to income investors than deep-value buyers.

Silver has rebounded sharply after a brutal 30–40% pullback, driven by geopolitical tensions and renewed macro uncertainty. Against this backdrop, Investigator Resources Ltd (ASX: IVR) — whose share price has more than tripled over the past year — has pulled back from recent highs as traders de-risk. The key question now is whether silver’s renewed surge signals another leg higher, offering leveraged upside for IVR, or just more short-term volatility.

We argue that despite cyclical and integration risks, Ansell’s improving margins and disciplined capital execution support a stable medium-term outlook. Technically and fundamentally, the A$28–30 range appears to represent a key support zone and a potentially attractive long-term entry level, provided earnings stability is maintained.

BlueScope is an integrated flat steel producer combining upstream steelmaking with higher‑margin, branded building products, giving it resilience across cycles. Around half of earnings are leveraged to the U.S. through North Star, where profitability depends on steel‑to‑scrap spreads rather than iron ore, providing structural margin support. In 1H FY2026, BlueScope delivered strong earnings growth despite weak HRC prices, driven by disciplined cost control and solid North American performance, underscoring its leverage to U.S. construction activity rather than pure commodity steel cycles.

Hot Chili Limited is a pre-revenue copper developer focused on its large-scale Costa Fuego project in Chile, supported by strategic water infrastructure and long-term exposure to the global copper supply deficit theme. However, its recent share price weakness has been driven by a discounted capital raising, ongoing dilution risk, high cash burn, valuation concerns, and broader copper-sector volatility. Technically, the stock has entered a correction phase, with downside support levels around A$1.25–1.30, A$1.15 and near A$1.00, while a sustained break below the A$0.80–0.90 zone would signal a deeper trend reversal.

Bega Group has evolved from a regional dairy co-operative into a diversified branded food business spanning cheese, spreads and milk beverages, combining defensive staple demand with branded exposure. The investment case now hinges on whether recent operational improvements can translate scale and strong household brands into sustained margin and ROIC expansion. However, with limited product innovation and rising marketing spend largely aimed at defending shelf space, the company’s growth profile remains more defensive than structurally transformative.

REA Group is not a cyclical advertising or media business but a durable digital infrastructure monopoly at the centre of Australia’s property economy, monetising the country’s most valuable consumer intent. The market’s focus on listings cycles, rates, and short‑term sentiment misses the point: REA’s core engine is yield, its moat is data, and its next phase of growth will be driven by AI‑led personalisation, deeper monetisation, and an expanding financial services ecosystem.

CBA is trading near all-time highs, reflecting its dominant market share, strong 13.8% ROE, resilient earnings growth and fully franked dividends. While 1H26 results showed solid lending and deposit growth ahead of the broader economy, the stock’s ~30x earnings multiple leaves limited margin for error. At current levels, much of the good news appears priced in, with valuation risk emerging if margins compress or growth moderates.

Woodside Energy Group currently looks more like a cyclical value income stock than a value trap, supported by a 6%+ fully franked dividend, reasonable valuation and low production costs, despite compressed free cash flow during its heavy investment phase. The key risks remain commodity prices and execution, with sustained strength above A$27 and firmer oil/LNG markets needed to confirm upside momentum.